Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003752	u-bkvnh	— (—)	193	726	100.00%	Distribution not available
3003752	u-bkvnh	u/ml (—)	52	98	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

148

148.95

295.32

4.3

3.2

—

L04AA Selective immunosuppressants

139

117.52

272.93

4.1

2.8

—

Renal failure

152

93.28

268.50

4.2

3.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

179

64.20

231.55

4.0

2.7

—

Dental caries

111

110.87

214.63

4.7

2.2

—

ILD medications: immunosuppressive drugs

192

265.65

184.93

4.1

1.1

—

Renal tubulo-interstitial diseases

150

27.46

181.29

4.0

3.6

—

L04AD Calcineurin inhibitors

177

309.84

175.34

4.1

7.7

—

First line medication for Crohn's disease

167

57.05

174.55

4.5

2.1

—

Glomerular diseases

45.57

168.03

4.2

4.5

—

Nephropathy related operations

158

272.79

155.41

4.4

3.8

—

Kidney transplant status

150

270.85

148.53

4.4

3.8

—

Dialysis, with operation codes

151

259.38

148.10

4.2

3.8

—

Azathioprine

36.95

135.32

5.8

3.7

—

ILD medications

181

110.64

132.86

4.3

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

168

118.91

125.57

4.3

1.1

—

Dentofacial anomalies [including malocclusion]

68.57

125.17

7.0

2.2

—

Other diseases of hard tissues of teeth

104

28.79

124.62

5.8

1.6

—

Glomerulonephritis

44.50

117.93

5.3

5.8

—

Molar incisor enamel hypoplasia

40.10

117.32

7.0

6.4

—

L04AX Other immunosuppressants

16.11

115.44

5.5

2.6

—

Second line medication for Crohn's disease

15.76

115.30

5.5

2.5

—

Persons encountering health services for specific procedures and health care

139

14.87

115.19

3.8

—

Hypoplasia of dental enamel, including avohilmo

54.10

114.41

7.1

6.3

—

Hypoplasia of dental enamel , including avohilmo

38.27

110.13

7.1

6.4

—

Care involving dialysis

116

150.63

109.95

4.0

4.4

—

Fever of other and unknown origin

18.38

106.44

4.0

2.1

—

Acute tubulo-interstitial nephritis

24.29

106.23

4.1

3.5

—

Nephrotic syndrome

56.46

104.03

5.8

6.7

—

Other disorders of kidney and ureter

52.53

90.65

3.9

4.5

—

Hypertensive diseases (excluding secondary)

19.49

85.15

5.2

3.8

—

Antihypertensive medication - note that there are other indications

104

17.82

84.56

5.6

3.4

—

Septicaemia

15.19

82.53

4.5

4.4

—

Other septicaemia

16.03

81.25

4.4

4.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

10.45

80.51

4.8

3.2

—

Explicit Sepsis

14.52

80.45

4.5

4.6

—

Hypertension

106

13.97

80.29

4.9

3.0

—

Hypertensive diseases

106

13.66

79.50

4.9

3.1

—

Genitourinary diseases

20.10

75.89

5.9

3.5

—

Cardiovascular diseases (excluding rheumatic etc)

104

12.28

75.25

5.1

4.2

—

GASTRO-related operations

32.46

74.73

4.5

2.0

—

Any gastric operation

32.46

74.73

4.5

2.0

—

Other problems related to primary support group, including family circumstances

16.78

74.29

7.2

4.6

—

Other bacterial diseases

107

9.15

73.00

4.0

3.6

—

Intestinal infectious diseases

100

8.56

69.47

4.3

3.0

—

Extracorporeal dialysis

98.41

69.34

3.6

4.9

—

Congenital malformations of the urinary system

19.05

68.42

4.4

6.3

—

Dentinal caries

93.95

67.78

3.7

2.5

—

Viral and other specified intestinal infections

14.34

62.15

6.1

4.2

—

Other disorders of gingiva or/and edentulous alveolar ridge

+∞

61.79

6.6

0.0

—

Gingival hyperplasia

+∞

60.94

6.7

0.0

—

Other dialysis

89.41

60.70

5.1

4.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

10.94

60.59

7.0

3.7

—

Direct fill therapy

13.38

60.44

4.9

6.2

—

Cardiovascular diseases

10.92

60.34

5.3

4.5

—

Heart failure, not strict

11.26

58.11

2.5

4.0

—

Anaemias

31.54

58.11

4.4

4.7

—

Viral infections characterized by skin and mucous membrane lesions

8.99

57.05

4.7

4.3

—

Inflammatory bowel disease treatment related agents

109

7.21

56.34

5.0

2.6

—

Bacterial infection, other or unspecified

12.12

55.87

4.0

3.5

—

Diseases of oral cavity, salivary glands and jaws

14.45

54.50

5.1

1.6

—

Diseases of pulp and periapical tissues

27.75

52.98

1.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

100

6.74

51.96

3.9

3.8

—

Molar incisor enamel hypoplasia, with caries

76.22

49.44

7.0

8.2

—

Aplastic and other anaemias

12.18

48.82

3.5

3.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

15.61

48.52

3.2

6.0

—

Metabolic disorders

7.31

47.78

2.7

4.4

—

Certain infectious and parasitic diseases

12.03

46.88

3.9

2.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

14.54

46.74

3.2

5.6

—

Gastrointestinal diseases

21.61

45.23

4.5

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

8.10

44.52

4.2

2.6

—

Disorders resulting from impaired renal tubular function

85.03

44.18

3.9

4.8

—

Other viral diseases

7.48

43.43

5.7

4.1

—

Excessive attrition of teeth

18.02

43.04

6.5

1.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.69

42.43

4.5

5.9

—

Erosion of teeth, including avohilmo

28.09

41.66

6.1

1.8

—

Care involving use of rehabilitation procedures

9.50

41.48

3.6

4.1

—

Congenital malformations, deformations and chromosomal abnormalities

6.40

39.52

3.7

4.1

—

Implicit viral Sepsis

17.84

39.42

3.4

5.3

—

Viral Sepsis

17.84

39.42

3.4

5.3

—

Viral warts

17.34

37.63

5.6

5.4

—

Other disorders of fluid, electrolyte and acid-base balance

17.62

37.11

3.4

4.7

—

Glomerular disorders in diseases classified elsewhere

54.22

36.37

2.1

3.6

—

Implicit bacterial Sepsis

14.19

35.47

2.6

3.5

—

Implicit Sepsis

7.39

35.44

2.8

3.7

—

Any reimbursement code in KELA

39.43

34.70

3.6

2.4

—

Bacterial Sepsis

10.86

34.23

3.2

3.8

—

Anomalies of dental arch relationship, including avohilmo

9.02

34.14

6.9

4.2

—

General examination and investigation of persons without complaint and reported diagnosis

11.32

33.66

5.0

1.4

—

Hypoplasia of dental enamel, prenatal , including avohilmo

24.51

33.59

8.0

6.6

—

7.38

33.42

3.7

2.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.38

33.42

3.7

2.3

—

Influenza and pneumonia

117

4.84

33.35

3.9

3.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

6.59

31.74

2.8

3.7

—

Infections, IBD-co-morbidities

16.70

31.13

3.0

5.5

—

Cystic kidney disease

71.91

31.03

3.0

4.2

—

Disorders of other endocrine glands

5.74

28.85

4.8

5.0

—

Other viral diseases, not elsewhere classified

6.58

28.76

6.3

4.5

—

Other reaction to severe stress, and adjustment disorders

7.56

28.39

3.9

2.9

—

Dental caries 2 and operation codes

5.39

27.79

4.7

2.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.61

27.77

3.8

—

Diabetic nephropathy

63.46

27.75

1.1

1.2

—

Dental caries 2

5.24

27.33

4.6

2.9

—

Other and unspecified anaemias

8.90

27.11

3.3

3.5

—

Other anaemias

8.88

27.02

3.3

3.5

—

Other disorders of urethra and urinary system

6.67

26.95

4.1

3.2

—

Diseases of peritoneum

62.44

26.95

3.7

2.0

—

General symptoms and signs

5.82

26.62

3.3

1.9

—

Zoster [herpes zoster]

16.97

26.33

2.5

2.7

—

Bronchitis

5.17

26.25

3.6

2.2

—

Other metabolic disorders

15.39

26.23

3.1

3.5

—

Diabetic nephropathy, excluding more controls

53.64

25.69

1.1

1.0

—

Nausea and vomiting

6.37

25.36

5.2

5.0

—

Hyperlipidaemia, other/unspecified

18.08

25.01

1.4

2.2

—

Other retinal disorders

7.15

24.62

1.6

2.5

—

Examination and observation for other reasons

9.79

24.55

4.4

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

121

4.18

24.54

3.9

4.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

9.07

24.38

3.9

1.4

—

Insulin, fast-acting (human)

12.04

23.83

1.2

3.0

—

Diabetic retinopathy, strict definition

16.15

23.73

1.2

—

Pneumonia, organism unspecified

107

4.40

23.60

4.1

4.0

—

Provisional assignment of new diseases of uncertain etiology

5.86

22.99

3.6

4.0

—

Codes for special purposes

5.86

22.99

3.6

4.0

—

Certain disorders involving the immune mechanism

9.06

22.94

5.0

3.9

—

All influenza

7.64

22.90

4.7

—

Endocrine, nutritional and metabolic diseases

4.80

22.78

3.6

5.2

—

Complications of medical and surgical care

5.50

22.68

2.7

3.0

—

All pneumoniae

129

3.91

22.52

3.9

4.1

—

Crowding of teeth, including avohilmo

6.72

22.38

7.4

5.4

—

Hypoplasia of dental enamel, prenatal

56.41

21.82

8.0

6.3

—

Acute upper respiratory infections

4.83

21.75

4.2

2.4

—

Chronic periapical parodontitis

38.71

21.68

1.3

2.3

—

Otitis media, unspecified

7.55

21.17

5.2

5.3

—

Complications of surgical and medical care, not elsewhere classified

4.45

20.95

2.7

3.1

—

Persons encountering health services in other circumstances, wide

3.93

20.91

3.5

3.8

—

Disorders of lens

6.84

20.62

2.9

2.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

104

4.58

20.44

5.7

4.4

—

Medical observation and evaluation for suspected diseases and conditions

8.11

20.28

3.2

1.4

—

Acute suppurative otitis media

5.87

20.25

5.8

4.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

132

3.67

19.78

4.0

—

Other cataract

9.60

19.54

3.8

2.8

—

Headache

6.46

19.54

3.8

2.1

—

Covid-19 confirmed case

7.08

19.46

3.2

3.3

—

Gingivitis and periodontal diseases

7.64

19.07

3.5

1.6

—

Hypertension, essential

7.04

19.01

1.4

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.77

18.22

2.7

3.3

—

Other bacterial intestinal infections

13.10

17.66

2.4

3.8

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

14.84

17.66

7.4

6.5

—

Disorders of choroid and retina

5.06

17.57

1.5

2.3

—

Symptoms and signs involving the urinary system

4.45

17.44

3.8

3.5

—

Polyneuropathies and other disorders of the peripheral nervous system

10.58

17.32

2.4

3.2

—

Unspecified haematuria

7.24

17.30

4.4

3.2

—

Diabetic retinopathy

9.88

17.06

1.3

—

Agranulocytosis

13.38

16.79

5.1

3.6

—

Other and unspecified polyneuropathies, also in other diseases

15.03

16.75

2.0

2.5

—

Other disorders of skin and subcutaneous tissue

4.77

16.60

2.9

3.3

—

Other heart diseases

5.67

16.57

4.5

4.2

—

Hypermetropia

7.72

16.55

6.9

6.8

—

Disorders of lipoprotein metabolism and other lipidaemias

5.43

16.43

1.3

2.5

—

Speech and linguistic disorders, excluding more controls

6.66

16.08

7.3

5.2

—

4.23

16.00

3.9

2.3

—

Certain conditions originating in the perinatal period

5.26

15.81

6.3

5.3

—

Nonsuppurative otitis media

5.59

15.74

5.4

4.6

—

Melanocytic naevi

7.60

15.68

3.4

3.7

—

Persons encountering health services for examination and investigation

6.90

15.58

3.5

1.4

—

COPD/asthma/ILD related infections

4.62

15.57

3.9

2.3

—

COPD/asthma related infections

4.62

15.57

3.9

2.3

—

Neoplasms

3.56

15.24

3.8

4.8

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

28.71

15.17

2.3

—

Diseases of the eye and adnexa

3.79

14.82

4.1

4.4

—

Suppurative and unspecified otitis media

4.64

14.65

5.5

3.6

—

Other diseases of urinary system

3.51

14.52

3.9

3.6

—

Lack of expected normal physiological development

20.71

14.05

6.1

5.0

—

Persons with potential health hazards related to communicable diseases

107

3.81

13.80

4.9

—

Symptoms and signs concerning food and fluid intake

23.80

13.76

7.4

4.6

—

Deep bite

4.77

13.74

6.7

6.1

—

Gout

11.40

13.62

1.7

1.8

—

Cytomegalovirus infection, IBD co-morbidity

34.70

13.54

3.6

4.4

—

Volume depletion

11.70

13.53

3.6

4.7

—

Disorders of refraction and accommodation

4.21

13.50

6.7

4.8

—

Anxiety disorders, excluding more controls

3.89

13.46

4.4

2.2

—

Need for other prophylactic measures

13.08

13.37

6.9

—

4.74

13.37

7.3

6.5

—

13.03

13.37

2.4

1.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

21.18

13.31

1.6

2.6

—

Type 1 diabetes

4.34

13.26

1.5

5.5

—

Diabetic retinopathy, excluding more controls

16.93

13.25

1.3

—

Heart failure and antihypertensive medication

26.44

13.19

3.5

1.2

—

Gout, FINNGEN

10.01

13.12

1.7

1.6

—

Neurotic, stress-related and somatoform disorders

104

3.42

13.12

4.2

2.7

—

Osteopathies and chondropathies

4.47

13.12

2.9

3.8

—

Anxiety disorders

104

3.41

13.05

4.2

2.7

—

Sub-endpoint used in defining T1D endpoints

4.28

12.96

1.5

5.5

—

Rare circulating lymphoid malignancy

10.89

12.87

4.5

6.4

—

Disorders of parathyroid gland

28.02

12.86

1.9

2.0

—

Hypo-osmolality and hyponatraemia

22.48

12.85

3.4

4.5

—

Heart failure,strict

8.02

12.80

3.5

4.0

—

Oedema, not elsewhere classified

8.85

12.79

3.0

1.7

—

Bacterial intestinal infections, IBD co-morbidities

8.11

12.74

2.4

4.0

—

Melanocytic naevi of trunk

11.85

12.63

3.2

3.1

—

Convulsions, not elsewhere classified

8.00

12.55

5.2

3.0

—

Hyperparathyroidism

31.68

12.48

1.9

1.2

—

Other acute lower respiratory infections

110

3.56

12.45

4.8

4.2

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

10.11

12.25

4.5

6.2

—

Melanocytic naevi

5.80

12.24

3.4

3.3

—

Tooth eruption problems

4.79

12.17

5.1

4.9

—

Cough

4.06

12.06

4.5

4.6

—

Personal history of other diseases and conditions

26.62

12.00

5.0

1.8

—

Other diseases of blood and blood-forming organs, wide

6.26

11.99

4.9

3.9

—

Invasive ventilation

12.05

11.74

6.5

5.0

—

Diseases of middle ear and mastoid

3.71

11.73

4.6

3.2

—

Statin medication

4.54

11.72

2.0

2.4

—

Diabetic neuropathy

11.96

11.66

1.1

1.2

—

4.57

11.64

7.5

6.7

—

Other disorders starting during childhood or adolecense, excluding more controls

5.83

11.55

8.4

5.5

—

Coagulation defects, purpura and other haemorrhagic conditions

5.69

11.46

3.8

5.3

—

Infections of the skin and subcutaneous tissue

123

3.32

11.36

4.0

4.2

—

Hypertensive heart and/or renal disease

24.83

11.01

3.8

3.4

—

Peripheral artery disease

7.61

11.01

1.1

1.5

—

Insulin, fast-acting or short human

4.00

10.89

1.4

5.3

—

Insulin, fast-acting

4.00

10.89

1.4

5.3

—

Crossbite

4.29

10.81

6.9

6.3

—

Lymphoid leukaemia

9.34

10.77

4.8

6.0

—

Lymphoid leukaemia

9.34

10.77

4.8

6.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

18.03

10.74

6.4

6.6

—

Other disorders involving the immune mechanism, not elsewhere classified

18.01

10.74

6.4

6.6

—

Malignant neoplasm, wide definition for exclusion

3.08

10.61

2.9

3.8

—

Other pulmonary diagnosis

4.58

10.61

3.2

2.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3.08

10.61

2.9

3.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

10.42

3.3

0.0

—

Acute bronchiolitis

4.04

10.30

5.9

6.1

—

All influenza (not pneumonia)

6.31

10.26

5.2

5.5

—

Other disorders of teeth and supporting structures

23.36

10.23

2.7

2.5

—

Other endocrine disorders

4.41

10.11

6.2

7.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3.02

10.08

3.0

3.8

—

Excluding asthma or asthma-COPD overlap

4.44

9.95

3.2

2.1

—

Disorders of psychological development

3.70

9.89

7.0

5.8

—

Vitreous haemorrhage

26.07

9.80

1.2

1.0

—

Dental caries 1 and operation codes

3.42

9.46

4.3

3.4

—

Bleeding

100

3.06

9.43

2.5

3.9

—

Varicella [chickenpox]

8.62

9.35

4.0

5.6

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.38

9.23

6.5

4.8

—

Acute sinusitis

4.38

9.21

3.4

1.9

—

Type 1 diabetes, wide definition

3.81

9.19

1.4

5.5

—

Malignant neoplasm

2.94

9.09

3.1

3.6

—

Mycoses

5.01

9.08

3.1

3.6

—

Other medical care

6.37

9.06

3.1

3.4

—

COPD differential diagnosis

4.18

9.03

3.3

2.3

—

ILD differential diagnosis

4.17

9.03

3.3

2.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

7.28

8.85

6.8

7.1

—

Other and unspecified tonsillitis

4.34

8.85

4.7

2.8

—

Hernia

107

2.85

8.84

5.2

3.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.74

8.75

1.8

3.6

—

Dental pulpitis 2

3.81

8.73

4.6

4.4

—

Erysipelas

4.95

8.72

1.3

1.4

—

Type 1 diabetes, wide definition, subgroup 1

3.85

8.65

1.1

5.5

—

Cystitis

3.18

8.65

3.1

3.6

—

Neurological diseases, wide definition

4.65

8.47

4.8

5.3

—

Dermatitis

3.33

8.45

4.2

3.4

—

Actinic keratosis

8.71

8.44

1.0

1.1

—

Disorders of vitreous body

5.20

8.41

1.2

1.5

—

Candidiasis

7.51

8.41

3.6

4.8

—

Acute pharyngitis

5.49

8.40

6.4

3.6

—

Other and unspecified dermatitis

3.61

8.26

4.5

3.6

—

7.53

8.22

1.2

1.1

—

Melanocytic naevi of trunk

14.48

8.19

3.2

3.9

—

Tramadol

3.86

8.19

1.6

1.2

—

Oxycodone

6.16

8.16

2.0

1.1

—

Senile cataract

5.36

8.14

1.2

1.6

—

Disorders of vitreous body and globe

5.03

8.10

1.2

1.8

—

Immunodeficiencies

9.14

8.09

3.2

4.5

—

Cerebrovascular diseases (FINNGEN)

7.75

8.06

2.5

1.9

—

Hypertensive Heart Disease

19.64

7.99

4.4

3.4

—

Dental operations

5.13

7.93

3.2

1.3

—

Otitis externa

4.26

7.92

6.2

4.3

—

Skin changes due to chronic exposure to nonionizing radiation

8.01

7.91

1.0

1.1

—

Heart failure, strict

4.64

7.87

3.6

2.8

—

Malaise and fatigue

4.84

7.82

2.3

2.5

—

Symptoms and signs involving the digestive system and abdomen

104

2.55

7.80

4.8

4.0

—

Venous thromboembolism

4.86

7.79

1.7

1.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

6.93

7.77

1.1

1.6

—

Childhood asthma (age<16)

6.89

7.71

3.9

3.5

—

Childhood asthma (age<16), excluding more controls

6.88

7.70

3.9

3.5

—

Irregular menses

4.39

7.70

2.4

1.8

—

Type 2 diabetes, wide definition

3.59

7.51

1.2

1.4

—

Any event in cancer register

2.71

7.49

3.0

3.4

—

Other disorders of bone

5.18

7.44

3.5

2.9

—

Speech and linguistic disorders

3.39

7.42

7.3

6.1

—

Otitis externa, unspecified

5.92

7.37

5.7

4.9

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.09

7.36

3.8

1.9

—

All-cause Heart Failure

4.56

7.35

3.6

2.8

—

Retinal haemorrhage

+∞

7.30

1.9

0.0

—

Non-ischemic cardiomyopathy

6.28

7.23

4.8

3.7

—

Enterocolitis due to Clostridium difficile

15.75

7.22

2.7

—

Disorders of skin appendages

3.21

7.21

4.3

3.5

—

Bacterial, viral and other infectious agents

7.71

7.12

6.1

4.8

—

Dental pulpitis 2, only avohilmo

3.31

7.06

4.7

4.0

—

Diseases of arteries, arterioles and capillaries

3.73

7.05

1.4

2.0

—

Other benign neoplasms of skin

5.29

7.05

2.1

3.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.95

7.05

1.4

4.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.64

7.02

8.1

5.8

—

Hyperkinetic disorders, excluding more controls

4.88

6.91

7.1

5.0

—

Hypothyroidism (congenital or acquired)

9.58

6.90

2.3

5.0

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

13.77

6.88

2.2

3.9

—

Glaucoma

4.68

6.82

1.6

1.7

—

Recurring oral aphthae, including avohilmo

5.43

6.76

5.9

4.3

—

Noninflammatory disorders of female genital tract

4.58

6.71

2.9

2.5

—

Dental caries, including avohilmo

3.09

6.60

4.6

3.8

—

Dental caries 1

3.09

6.60

4.6

3.8

—

Insulin, intermediate and long-acting

3.05

6.60

1.1

4.5

—

Distal bite

4.01

6.56

8.1

6.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.73

6.54

2.3

1.3

—

Cutaneous abscess, furuncle and carbuncle

4.15

6.54

3.1

3.6

—

Other strabismus

3.43

6.52

5.6

5.3

—

Short stature, not elsewhere classified

3.73

6.48

5.8

7.2

—

Benign neoplasms

2.72

6.42

3.2

4.0

—

Osteoporosis

6.82

6.31

2.5

3.6

—

Rash and other nonspecific skin eruption

6.68

6.31

5.2

5.3

—

Viral pneumonia

5.46

6.28

2.7

4.5

—

Hypothyroidism and >3 levothyroxin purchases

8.95

6.28

2.4

5.0

—

Hypothyroidism, levothyroxine purchases

8.95

6.28

2.4

5.0

—

Other diseases of arteries and capillaries

18.04

6.26

2.0

1.8

—

Acute nephritic syndrome

+∞

6.26

3.5

0.0

—

Intermittent heterotropia

4.43

6.23

5.9

7.1

—

Symptoms and signs involving the skin and subcutaneous tissue

108

2.77

6.23

3.8

3.7

—

Opioids

2.95

6.22

1.8

1.9

—

Retention of urine

6.20

6.11

1.2

2.7

—

Pain, not elsewhere classified

5.79

6.10

3.6

2.3

—

Insulin medication

2.73

6.10

1.4

4.4

—

Recurring oral aphthae

12.56

6.08

6.7

4.9

—

Strabismus

3.01

6.03

5.2

5.3

—

Other heart diseases, wide

131

2.27

6.01

4.1

3.7

—

Disorders of sclera, cornea, iris and ciliary body

3.15

6.00

2.0

3.2

—

Cellulitis

3.87

5.97

4.3

4.6

—

Overjet

3.90

5.96

7.8

6.5

—

Phlebitis and thrombophlebitis (not including DVT)

6.26

5.95

1.2

1.6

—

Peripheral arterial reconstruction

15.01

5.90

1.1

1.0

—

Other congenital malformations of the digestive system

3.68

5.86

6.2

7.0

—

Speech therapy

4.38

5.76

3.6

3.5

—

Diseases of external ear

3.23

5.71

6.1

4.3

—

Bacterial pneumonia (organism specified)

3.18

5.70

3.2

3.5

—

Parodontitis or operation codes

2.83

5.65

1.8

1.7

—

Other disorders starting during childhood or adolescence

3.22

5.64

8.4

6.1

—

Nutritional anaemias

3.30

5.58

4.1

3.3

—

Asthma

3.47

5.51

2.9

2.1

—

Asthma (only as main-diagnosis), excluding more controls

3.61

5.48

3.0

2.2

—

All anxiety disorders

2.79

5.45

3.9

2.8

—

Diseases of the ear and mastoid process

106

2.24

5.44

3.6

2.5

—

Diseases of the skin and subcutaneous tissue

2.37

5.43

3.5

3.7

—

Immunodeficiency with predominantly antibody defects

16.12

5.41

3.8

6.2

—

Abnormal findings on examination of urine, without diagnosis

16.07

5.41

2.0

5.0

—

Other embolism and thrombosis

16.03

5.41

2.0

2.6

—

STROKE

3.56

5.39

1.6

2.3

—

Asthma (only as main-diagnosis)

3.55

5.39

3.0

2.1

—

Acute laryngitis and tracheitis

4.73

5.37

6.3

4.7

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.15

5.37

4.8

5.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

123

2.17

5.32

2.9

4.3

—

Used for control exclusion in common control thyroid runs

124

2.13

5.32

4.0

4.3

—

Amblyopia ex anopsia

4.36

5.30

5.2

7.2

—

Open bite

3.87

5.26

5.9

6.7

—

Diseases of the respiratory system

3.29

5.23

3.9

2.3

—

Drug-induced polyneuropathy

13.66

5.11

3.0

6.7

—

Asthma, excluding more controls

3.39

5.10

3.0

2.2

—

Inguinal hernia

2.64

5.10

6.2

3.2

—

Autoimmune diseases excluding thyroid diseases

125

2.13

5.08

2.9

4.3

—

Other noninfective gastroenteritis and colitis

3.00

5.08

4.1

5.5

—

Other disorders of bladder

13.35

5.07

1.1

1.8

—

Iron deficiency anaemia

3.30

5.06

4.2

3.5

—

Tooth agenesis EXCLUDE clefts and syndromes

4.47

5.03

5.0

6.3

—

Purpura and other haemorrhagic conditions

4.45

5.03

4.8

6.2

—

Enlarged lymph nodes

10.01

5.02

4.8

2.8

—

Polycystic ovarian syndrome, consortium definition

3.25

5.01

2.4

1.8

—

Non-allergic asthma (mode)

5.22

4.97

4.9

2.9

—

Non-allergic asthma (mode), excluding more controls

5.22

4.97

4.9

2.9

—

Dental pulpitis 4, only avohilmo

158

0.26

4.95

1.1

3.7

—

Congenital malformations and deformations of the musculoskeletal system

3.02

4.89

5.7

6.7

—

Systemic connective tissue disorders

4.06

4.89

2.7

3.0

—

Bacterial pneumoniae

3.25

4.82

3.5

3.4

—

Dental pulpitis 1, only avohilmo

155

0.27

4.80

1.1

3.6

—

Herpesviral [herpes simplex] infections

9.01

4.78

5.3

2.9

—

Polyuria

9.01

4.78

1.6

2.3

—

Undetermined asthma, excluding more controls

9.00

4.78

4.0

2.7

—

Undetermined asthma

9.00

4.78

4.0

2.7

—

Asthma (mode)

3.20

4.77

2.5

2.3

—

Pure hypercholesterolaemia

3.27

4.75

1.2

2.7

—

Acute bronchitis

2.77

4.62

3.7

4.6

—

Bacterial pneumonia, not elsewhere classified

3.27

4.60

3.4

3.3

—

Non-follicular lymphoma, hilmo, excluding all cancers

14.02

4.57

2.6

3.6

—

Neuromuscular dysfunction of bladder

14.02

4.57

2.3

2.0

—

Benign neoplasm: Skin of other and unspecified parts of face

14.02

4.57

1.1

1.0

—

Chronic periodontitis, including avohilmo

2.60

4.57

1.5

1.7

—

Coronary atherosclerosis

3.32

4.54

1.1

1.3

—

Parodontitis

2.59

4.53

1.5

1.7

—

Tonsillectomy and adenotomy

122

2.17

4.49

5.3

4.4

—

Covid-19 suspected case

3.59

4.48

5.1

3.5

—

Visual disturbances and blindness

2.65

4.47

4.0

4.4

—

Umbilical hernia

4.00

4.43

5.5

2.1

—

Diseases of oesophagus, stomach and duodenum

114

2.13

4.39

1.7

3.6

—

Keratitis

3.20

4.32

1.9

3.1

—

Other benign neoplasms of skin

3.50

4.32

2.1

2.6

—

Psychiatric diseases

2.14

4.31

4.4

2.9

—

Atrial fibrillation and flutter

7.25

4.30

1.2

2.1

—

Benign neoplasms

109

2.10

4.25

3.0

3.5

—

Abnormalities of breathing

109

2.13

4.24

3.5

3.7

—

Symptoms and signs involving the circulatory and respiratory systems

111

2.03

4.18

4.6

3.7

—

Acute pancreatitis (for exclusion)

6.93

4.16

3.8

2.7

—

Excessive, frequent and irregular menstruation

3.90

4.14

3.2

2.3

—

Glaucoma suspect

4.35

4.08

1.8

1.6

—

Motor disorders, excluding more controls

4.09

4.08

6.4

6.3

—

Thrombocytopenia, unspecified

8.02

4.06

6.0

—

Gout, unspecified

8.01

4.06

2.3

1.8

—

Hypopituitarism

3.52

4.04

6.6

6.9

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.68

4.03

7.0

6.8

—

Exclusions for E4_PCOS_BROAD

2.76

4.00

6.4

5.7

—

Hernia of abdominal wall

2.93

4.00

5.6

2.3

—

Astigmatism

3.94

3.97

8.5

7.1

—

Fitting and adjustment of other devices

6.44

3.93

3.9

3.6

—

Anxiety (asthma-related co-morbidities)

2.34

3.93

3.9

3.0

—

Disorders of gallbladder, biliary tract and pancreas

2.24

3.93

3.7

2.1

—

Fracture of rib(s), sternum and thoracic spine

4.17

3.88

1.1

2.2

—

Viral pneumonia (unknown virus, not influenza)

7.29

3.86

2.9

5.0

—

In situ neoplasms

6.13

3.83

1.3

1.1

—

Other anxiety disorders

2.80

3.82

2.4

2.6

—

Pruritus

6.01

3.81

2.1

2.9

—

Sequelae of external causes of morbidity and mortality

3.80

2.5

3.0

—

Acute lymphocytic leukaemia

8.97

3.80

5.3

7.0

—

Hard cardiovascular diseases

2.55

3.78

2.5

2.2

—

Autoimmune diseases

129

1.90

3.77

3.2

4.3

—

Other coagulation defects

8.77

3.77

2.3

3.4

—

Non-follicular lymphoma

8.76

3.77

2.6

—

Male infertility

12.03

3.76

1.2

1.0

—

Any mental disorder

2.02

3.71

4.5

2.9

—

Chondropathies

4.00

3.69

4.3

2.9

—

Complications of procedures, not elsewhere classified

2.42

3.69

2.3

3.0

—

Gout, idiopatic and unspecified

6.67

3.67

2.3

1.7

—

Codeine

2.53

3.58

1.4

—

Acute lymphocytic leukaemia, helper endpoint

7.97

3.58

5.3

6.7

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

7.97

3.58

5.3

6.7

—

Abdominal and pelvic pain

101

1.99

3.57

4.7

3.9

—

Chronic pancreatitis

7.79

3.55

2.0

2.4

—

Gastroduodenal ulcer

7.76

3.55

1.7

2.0

—

Ischemic heart diseases

2.58

3.53

2.2

1.8

—

Continuous positive airway pressure

3.45

3.51

6.8

5.7

—

Acute pancreatitis

5.30

3.50

3.8

2.8

—

Chronic gastritis

6.16

3.50

1.0

1.8

—

Cardiomyopathy, other and unspecified

10.02

3.49

3.3

6.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

10.01

3.49

3.5

2.0

—

COPD-related respiratory insufficiency

10.01

3.49

1.0

—

Noninfectious colitis NAS

3.55

3.48

2.1

4.6

—

Depression medications

6.47

3.45

3.1

4.7

—

Pain (limb, back, neck, head abdominally)

2.02

3.42

4.8

4.3

—

Embedded and impacted teeth

2.57

3.42

4.4

4.3

—

Parodontitis and operation codes

2.35

3.41

1.5

1.7

—

Cardiomyopathy

5.00

3.36

3.0

5.1

—

Acne

3.25

3.33

6.3

4.3

—

Dental caries 1 and operation codes, only avohilmo

0.26

3.32

1.8

5.3

—

Diseases of the musculoskeletal system and connective tissue

1.97

3.31

4.7

5.2

—

Delayed milestone in childhood

2.59

3.28

6.7

7.5

—

Seborrhoeic keratosis

8.58

3.26

2.0

—

Procreative management

2.18

3.18

5.0

5.1

—

Type 2 diabetes

2.25

3.17

1.3

1.6

—

Infections with a predominantly sexual mode of transmission

3.08

1.4

1.7

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

5.05

3.06

5.5

6.0

—

Orchitis and epididymitis

5.01

3.05

3.5

3.8

—

Other neurological diseases

2.36

3.04

2.1

2.9

—

Other congenital malformations of upper alimentary tract

10.17

2.99

7.0

5.6

—

Malnutrition

4.75

2.92

4.5

6.5

—

Abscess of anal and rectal regions

4.71

2.91

1.3

4.7

—

Injury of muscle and tendon at wrist and hand level

4.71

2.91

1.1

2.0

—

Sequelae with surgical and medical care as external cause

4.71

2.91

3.1

2.6

—

Specific development disorders of scholastic skills

2.98

2.91

6.4

5.9

—

In situ neoplasms

4.09

2.88

1.3

1.1

—

Haemolytic anaemias

6.69

2.87

8.0

4.9

—

Diseases of the digestive system

2.36

2.87

2.3

3.9

—

Unspecified privation

5.39

2.87

2.9

4.2

—

Use of pramipexole

5.39

2.86

1.4

2.6

—

Misadventures to patients during surgical and medical care

6.67

2.86

2.5

1.0

—

Explicit bacterial Sepsis

6.67

2.86

6.2

5.6

—

121

2.05

2.85

4.4

5.0

—

Asthma, unspecified (mode), excluding more controls

3.20

2.83

4.3

2.1

—

Mandibular retrognathia

3.05

2.79

9.2

5.7

—

Ischaemic heart disease, wide definition

2.45

2.78

1.1

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.54

2.77

3.1

—

Embedded teeth, including avohilmo

3.92

2.77

3.0

3.8

—

DVT of lower extremities and pulmonary embolism

3.90

2.76

2.1

1.4

—

Coxibs

0.00

2.76

0.0

1.7

—

Cerebral cysts

8.35

2.75

2.4

4.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

8.34

2.75

4.4

4.7

—

Amenorrhoea

8.34

2.75

3.0

—

Hypokalaemia

8.34

2.75

5.6

5.2

—

Benign neoplasm of other and ill-defined parts of digestive system

8.34

2.75

1.0

2.7

—

Dental caries 3 and operation codes

1.90

2.75

3.9

4.6

—

Specific development disorders of speech and language

2.54

2.74

8.0

6.5

—

Asthma, unspecified (mode)

3.11

2.73

4.3

2.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

5.00

2.72

2.1

3.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.29

2.72

1.0

4.2

—

Dental caries 3 and operation codes, only avohilmo

112

0.36

2.71

5.3

5.1

—

Budesonide

6.01

2.69

1.0

1.6

—

Nontraumatic intracranial haemmorrhage

6.00

2.69

2.8

2.6

—

Injuries to the thorax

2.59

2.69

1.4

2.4

—

Triptan medication for migraine, single purchase ok

116

0.29

2.61

2.2

3.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

116

0.29

2.61

2.2

3.2

—

Pain in limb

115

1.89

2.60

4.1

3.8

—

Nail disorders

4.67

2.59

2.7

4.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

3.86

2.58

1.4

1.6

—

Diaphragmatic hernia

3.60

2.57

1.3

1.6

—

Hyperfunction of pituitary gland

7.16

2.55

3.0

4.7

—

Other otitis externa (chronic)

7.15

2.55

5.2

3.1

—

Other osteochondropathies

7.15

2.55

5.8

3.7

—

Other infectious diseases

7.15

2.55

2.8

3.4

—

Bronchitis, not specified as acute or chronic

7.15

2.55

1.6

2.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

7.15

2.55

4.4

5.4

—

Other complications of surgical and medical care, not elsewhere classified

5.46

2.54

2.5

2.6

—

Perforation of tympanic membrane

5.46

2.54

6.5

4.6

—

Noninfective enteritis and colitis

108

2.04

2.50

4.0

4.7

—

Hypothyroidism, strict autoimmune

2.29

2.49

1.8

3.3

—

Impacted cerumen

4.38

2.47

6.1

5.4

—

Nerve, nerve root and plexus disorders

1.97

2.47

1.5

2.1

—

Disturbance of activity and attention

2.39

2.46

7.1

5.3

—

Other and unspecified iron deficiency

2.67

2.44

5.1

3.9

—

Asthma-related infections

135

1.89

2.43

4.3

4.6

—

Asthma, hospital admission 2, infections

135

1.89

2.43

4.3

4.6

—

Other diseases of intestines

150

1.67

2.40

2.8

4.4

—

Disorders of synovium and tendon

2.37

2.39

2.9

2.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.20

2.38

2.3

1.9

—

Streptococcal septicaemia

6.26

2.37

7.0

5.0

—

Rosacea

6.26

2.37

4.4

2.6

—

Secondary uncertain malignant neoplasm

6.25

2.37

4.4

3.8

—

Atrophic disorders of skin

6.25

2.37

5.4

4.0

—

Visual disturbances

2.14

2.34

4.1

4.4

—

Polyarthropathies

1.94

2.32

2.2

3.5

—

Oral corticosteroids

1.94

2.28

2.3

2.1

—

Pain associated with micturition

4.62

2.27

4.2

5.8

—

Asthma-related pneumonia

2.15

2.23

4.4

5.1

—

Asthma, hospital admissions 3, pneumonia

2.15

2.23

4.4

5.1

—

Asthma-related pneumonia or sepsis

2.15

2.23

4.4

5.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.65

2.22

4.8

5.7

—

Cardiac murmurs and other cardiac sounds

2.53

2.21

7.7

6.2

—

Juvenile osteochondrosis

5.57

2.21

4.6

4.4

—

Gout, strict definition

5.56

2.21

1.4

1.9

—

Benign neoplasm of other and ill-defined parts of digestive system

5.56

2.21

1.0

2.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.82

2.19

1.0

1.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

107

1.96

2.19

3.3

4.8

—

Persons encountering health services in other circumstances

2.41

2.19

4.1

4.7

—

Hypothyroidism, drug reimbursement

5.96

2.17

3.2

4.7

—

Parodontitis, operation under 40 years and operation codes

3.69

2.15

3.9

2.9

—

Parodontitis, under 40 years, or operation codes

3.69

2.15

3.9

2.9

—

Soft tissue disorders related to use, overuse and pressure

3.69

2.15

1.9

1.5

—

Mental retardation, excluding more controls

3.29

2.14

7.0

—

Haemorrhage from respiratory passages

2.48

2.11

2.3

4.1

—

Other disorders of lacrimal gland

2.70

2.10

2.9

2.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.10

2.09

2.1

3.1

—

Dermatitis and eczema

157

1.63

2.09

3.4

3.7

—

Special screening examination for infectious and parasitic diseases

3.74

2.09

2.3

1.3

—

Parasetamol

1.87

2.08

2.5

3.0

—

Early onset COPD, excluding more controls

5.00

2.07

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.85

2.05

2.0

2.4

—

Other gastritis (incl. Duodenitis)

4.00

2.04

1.0

2.5

—

Congenital malformations of the circulatory system

1.98

2.03

6.1

6.3

—

Pulmonary embolism

4.00

2.03

2.7

1.6

—

Pulmonary heart disease

4.00

2.03

2.7

1.6

—

Stroke, including SAH

2.30

2.03

1.8

1.7

—

Disorders of puberty, all

3.10

2.02

4.3

6.4

—

Corneal ulcer

3.08

2.01

1.3

3.4

—

Functional dyspepsia

3.08

2.01

1.0

2.6

—

Urolithiasis

3.08

2.01

4.8

2.6

—

Mouth breathing

111

1.89

1.99

5.0

4.9

—

Pregnancy hypertension

2.80

1.96

1.0

1.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.35

1.94

3.9

4.1

—

Congenital deformities of feet

4.56

1.94

4.6

5.6

—

Seborrhoeic dermatitis

4.55

1.94

5.0

5.2

—

Dermatophytosis

4.55

1.94

3.2

3.3

—

Other disorders of ear

117

1.71

1.94

4.8

3.5

—

Conductive hearing loss, unspecified

3.75

1.93

5.3

4.4

—

Other and unspecified local infections of skin and subcutaneous tissue

3.75

1.93

5.2

5.0

—

Trigger finger

3.75

1.93

1.0

2.2

—

Other diseases of the digestive system

2.45

1.92

3.2

3.8

—

GI-bleeding

2.44

1.92

3.2

3.8

—

Sequelae of cerebrovascular disease

3.76

1.90

1.0

1.6

—

Congenital malformations of heart and great arteries

1.96

1.89

5.7

6.6

—

Other disorders of glucose regulation and pancreatic internal secretion

3.19

1.88

2.4

6.0

—

Cerebral palsy and other paralytic syndromes

3.18

1.88

3.1

4.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.18

1.88

1.3

2.2

—

Hyperplasia of prostate

2.85

1.87

1.1

1.0

—

Specific developmental disorder of motor function

2.42

1.86

6.4

7.1

—

Acne vulgaris

2.86

1.86

3.4

4.0

—

Cerebrovascular diseases

2.03

1.85

2.2

2.0

—

Urticaria

2.03

1.85

7.0

4.5

—

Heart failure and coronary heart disease

3.73

1.84

3.8

2.4

—

Diseases of male genital organs

1.73

1.84

4.6

4.9

—

Convergent concomitant strabismus

3.54

1.83

4.2

6.2

—

Other local infections of skin and subcutaneous tissue

3.53

1.83

5.2

4.8

—

Stroke, excluding SAH

2.35

1.83

1.9

1.8

—

Female genital prolapse

3.37

1.82

1.9

1.2

—

Pre-eclampsia

4.17

1.82

1.0

1.3

—

Pre-eclampsia or eclampsia

4.17

1.82

1.0

1.3

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

3.22

1.80

1.0

1.7

—

Chronic diseases of tonsils and adenoids

138

1.61

1.80

4.9

4.0

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

3.21

1.80

1.0

1.7

—

Phobic anxiety disorders

2.76

1.79

4.1

3.6

—

Other disorders of eyelid

2.56

1.78

1.4

2.6

—

Conjunctivitis (acute, non atopic)

1.91

1.78

4.8

5.2

—

Mood disorders, excluding more controls

1.83

1.77

2.1

1.8

—

Mild mental retardation

3.35

1.75

6.8

5.3

—

Emotional disorders starting during childhood or adolescence

2.33

1.74

4.8

6.3

—

Other skin changes

3.34

1.74

2.2

3.2

—

Diabetes mellitus

117

1.63

1.74

1.6

4.0

—

Urticaria and erythema

1.93

1.74

6.6

4.6

—

Contraceptive management

2.14

1.73

2.9

1.5

—

Abnormal findings on diagnostic imaging of lung

2.50

1.73

1.4

1.9

—

Visual impairment including blindness (binocular or monocular)

3.85

1.71

4.0

5.8

—

Motor disorders

2.31

1.70

6.4

7.5

—

Disorders of eyelid, lacrimal system and orbit

103

1.75

1.69

2.7

3.5

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.73

1.68

1.5

1.6

—

Disorders of optic nerve and visual pathways

3.16

1.66

2.8

5.3

—

Ischaemic Stroke, excluding all haemorrhages

2.44

1.66

1.5

1.9

—

Low back pain

103

0.37

1.65

1.4

2.1

—

Other systemic involvement of connective tissue

2.80

1.65

1.9

2.4

—

Lower back pain or/and sciatica

121

0.46

1.62

1.4

2.1

—

Other and unspecified injuries of lower leg

3.58

1.61

3.6

5.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.61

0.0

1.1

—

Other disorders of eye and adnexa

2.50

1.59

4.5

—

Scissor bite

2.33

1.59

8.8

6.2

—

Malignant neoplasm of breast

0.00

1.56

0.0

1.3

—

Inflammatory diseases of female pelvic organs

2.15

1.54

1.7

1.8

—

Parodontitis or/and operation codes

1.80

1.54

2.1

1.8

—

Colonic or urogenital fistula

2.43

1.53

3.1

1.7

—

COPD related to multimorbidity

2.97

1.53

1.0

1.5

—

Major coronary heart disease event

2.03

1.53

2.8

1.8

—

Ventral hernia

3.33

1.52

5.6

1.3

—

Autoimmune diseases related-to ILD

134

1.64

1.52

3.0

—

Contact with and exposure to communicable diseases

100

1.79

1.50

4.4

5.0

—

Diagnoses used for exclusion with ILD

2.86

1.50

4.3

1.6

—

Slow fetal growth and fetal malnutrition

2.88

1.50

5.0

6.6

—

Other systemic involvement of connective tissue (FG)

2.84

1.49

1.8

2.2

—

Dental caries 3

1.63

1.49

4.4

4.9

—

Diabetes, varying definitions

118

1.57

1.49

1.6

4.0

—

Benign neoplasm of colon, rectum, anus and anal canal

2.47

1.48

1.1

1.5

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.56

1.47

4.0

3.1

—

Respiratory distress of newborn

2.08

1.47

5.7

7.0

—

Persons encountering health services in circumstances related to reproduction

130

1.56

1.46

4.7

4.6

—

Anterior Iridocyclitis

2.50

1.45

2.3

—

Cardiovascular disorders originating in the perinatal period

3.19

1.44

5.8

5.7

—

Other disorders of optic [2nd] nerve and visual pathways

3.13

1.44

3.0

5.6

—

Basal cell carcinoma

2.53

1.43

1.0

1.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.92

1.43

6.0

4.8

—

Pulmonary heart disease, diseases of pulmonary circulation

2.73

1.43

2.7

2.3

—

Pregnancy, childbirth and the puerperium

0.00

1.42

0.0

2.8

—

Injury, poisoning and certain other consequences of external causes

1.70

1.42

4.5

5.1

—

Myocardial infarction

2.31

1.41

1.1

1.7

—

Non-invasive ventilation

2.68

1.40

6.0

4.0

—

Coronary angioplasty

2.71

1.38

5.2

2.6

—

Malignant neoplasm of breast, HER2-negative

0.00

1.37

0.0

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

114

1.56

1.36

1.5

3.9

—

Congenital malformations of pulmonary and tricuspid valves

2.97

1.36

8.4

7.1

—

Fracture of femur

2.61

1.35

3.7

4.1

—

Burns and corrosions of external body surface, specified by site

0.00

1.33

0.0

5.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

110

1.55

1.32

1.5

4.0

—

Codeine or tramadol medication

1.62

1.31

1.4

—

Other specified congenital malformation syndromes affecting multiple systems

2.51

1.30

3.8

8.0

—

Hyperkinetic disorders

1.81

1.30

7.1

5.9

—

Acute and subacute iridocyclitis

2.50

1.30

2.5

2.1

—

Unspecified acute lower respiratory infection

2.35

1.29

5.1

3.5

—

Disorders of puberty

2.79

1.28

4.2

6.5

—

Congenital deformities of hip

2.79

1.28

6.0

6.1

—

Allergic urticaria

2.78

1.28

7.8

5.9

—

Sleep apnoea, including avohilmo

106

0.49

1.28

2.8

2.1

—

Other disorders originating in the perinatal period

2.31

1.27

7.3

6.6

—

Coronary revascularization (ANGIO or CABG)

2.33

1.27

4.1

2.2

—

Disorders of lacrimal system

2.00

1.27

2.7

3.1

—

Other hearing loss

2.73

1.26

1.8

2.9

—

Abrasion of teeth

2.83

1.26

1.2

1.8

—

Allergic rhinitis

115

0.43

1.24

2.4

5.4

—

Benign neoplasm of colon, rectum, anus and anal canal

2.03

1.24

1.1

1.3

—

Non-allergic asthma

2.22

1.24

4.9

6.7

—

Exposure to unspecified factor

176

1.45

1.22

3.0

4.1

—

Disorders of speech understanding and production

2.05

1.22

8.3

7.1

—

Parodontitis, under 40 years and operation codes

2.63

1.21

2.8

2.9

—

Foreign body on external eye

2.63

1.21

3.0

2.7

—

Other soft tissue disorders, not elsewhere classified

124

1.49

1.21

4.0

3.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.79

1.20

3.6

3.9

—

Artificial joint operation, meniscal resection

0.46

1.20

1.5

1.6

—

Degeneration of macula and posterior pole

2.36

1.19

1.0

2.2

—

Impetigo

2.31

1.18

5.5

6.9

—

Conductive and sensorineural hearing loss

1.63

1.18

5.5

3.0

—

Other diseases of pleura

2.08

1.16

2.0

3.5

—

Mixed specific developmental disorders

1.94

1.16

6.9

—

Parodontitis, under 40 years

2.50

1.15

2.8

3.0

—

Hypoglycaemia, other or unspecified

2.50

1.15

1.8

6.3

—

Dysphagia

2.50

1.15

3.8

2.6

—

Non-selective monoamine reuptake inhibitors

0.00

1.14

0.0

1.4

—

Basal cell carcinoma, including avohilmo

2.40

1.14

1.0

1.4

—

Emergency coronary revascularization (for ACS)

2.05

1.13

4.1

2.0

—

Malignant neoplasm of digestive organs

2.46

1.13

4.0

1.8

—

Conotruncal defects

2.35

1.12

7.7

6.7

—

Allergic asthma (mode)

2.45

1.12

4.2

2.9

—

Allergic asthma (mode), excluding more controls

2.45

1.12

4.2

2.9

—

Open wound of lower leg

2.33

1.12

1.6

4.6

—

Fracture of skull and facial bones

2.00

1.12

4.6

3.2

—

Disorders of conjunctiva

160

1.47

1.10

4.4

4.1

—

Right ventricular outflow tract obstruction

2.40

1.09

8.4

6.9

—

Menorrhagia

2.28

1.09

3.3

1.6

—

Congenital malformations of the respiratory system

2.39

1.09

4.8

5.7

—

Early onset COPD

2.38

1.09

1.0

2.5

—

Hydrocele

2.38

1.09

6.4

4.8

—

Syncope and collapse

2.22

1.08

1.0

1.9

—

Other dorsopathies, not elsewhere classified

117

0.59

1.08

2.8

2.9

—

Superficial injury of ankle and foot

2.19

1.08

4.7

5.2

—

Iridocyclitis

2.19

1.08

2.3

2.8

—

Disturbances of skin sensation

2.19

1.08

2.6

1.9

—

Paracetamol of NSAID medication

0.45

1.07

3.2

5.5

—

Diverticular disease of intestine

1.85

1.07

1.3

1.4

—

Diabetes medication

121

1.46

1.06

1.6

3.8

—

Adverse effects, not elsewhere classified

1.92

1.06

4.7

5.2

—

Other degenerative diseases of the nervous system

2.37

1.05

1.4

1.0

—

Calculus of kidney and ureter

2.27

1.03

7.0

2.5

—

Conjunctivitis

155

1.46

1.03

4.7

4.2

—

Artrosis, including avohilmo

0.50

1.03

1.7

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.06

1.02

3.3

6.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.73

1.02

3.8

4.7

—

Finngen Rheumatological endpoints

110

1.45

1.00

2.6

3.1

—

External causes of morbidity and mortality

1.49

0.99

4.4

4.6

—

Transient ischemic attack

2.00

0.99

1.0

1.5

—

Heterophoria

2.18

0.98

5.8

6.4

—

Mental and behavioural disorders due to alcohol

1.71

0.98

2.1

—

Abnormalities of gait and mobility

2.18

0.98

3.6

5.0

—

Benign paroxysmal vertigo

2.17

0.98

1.2

2.4

—

Other disorders of penis

1.95

0.97

8.6

5.5

—

Myocardial infarction, strict

1.96

0.96

1.1

1.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.96

0.0

2.4

—

Fissure and fistula of anal and rectal regions

2.22

0.93

3.0

1.6

—

Personality disorders, excluding more controls

2.22

0.93

1.8

1.3

—

1.62

0.93

2.2

2.0

—

Hypothyroidism, other/unspecified

1.52

0.92

1.9

2.9

—

Substance abuse, excluding more controls

1.72

0.91

1.5

1.6

—

Abnormal findings on examination of blood, without diagnosis

1.67

0.90

2.8

3.7

—

Exclusion endpoint for clefts

2.08

0.89

3.8

7.4

—

Benign neoplasm: Colon

2.09

0.89

1.2

1.5

—

Other and unspecified effects of external causes

1.69

0.88

4.7

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.50

0.88

1.9

2.9

—

Fracture of shoulder and upper arm

1.64

0.87

2.7

4.5

—

Intestinal stricture

2.00

0.87

1.0

3.3

—

Ovarian cyst

2.04

0.86

1.8

1.6

—

Gastro-oesophageal reflux disease

1.56

0.86

2.0

3.7

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.72

0.86

5.5

3.7

—

Fracture of forearm

1.56

0.83

2.7

4.1

—

Impacted teeth

1.76

0.83

6.4

4.2

—

Benign neoplasm: Colon

1.90

0.82

1.2

1.3

—

1.59

0.82

2.0

2.1

—

Single delivery by forceps and vacuum extractor

0.00

0.82

0.0

1.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.53

0.82

1.9

2.6

—

Biguanides

0.55

0.80

1.4

—

Cardiodefibrillation

0.00

0.79

0.0

2.2

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

Injuries to the elbow and forearm

133

1.43

0.78

3.4

4.2

—

Premature rupture of membranes

0.00

0.78

0.0

1.4

—

Superficial injury of forearm

0.00

0.77

0.0

6.0

—

Other and unspecified disorders of psychological development

0.00

0.77

0.0

7.1

—

Other chronic obstructive pulmonary disease

1.78

0.76

1.0

2.3

—

Acute alcohol intoxication, ICD10

1.77

0.76

3.2

2.6

—

Fracture of foot, except ankle

1.70

0.75

5.6

3.4

—

Bacterial sepsis of newborn

2.11

0.75

8.4

6.9

—

Neurological diseases

134

1.32

0.75

3.6

4.7

—

Depression

125

1.38

0.75

2.0

2.9

—

Injuries to the ankle and foot

151

1.39

0.75

5.1

3.6

—

Aortic valve malfunction, age under 60 years

2.08

0.74

2.6

5.5

—

Soft tissue disorders

134

1.32

0.74

4.2

4.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.84

0.73

4.6

7.1

—

Acute alcohol intoxication

1.84

0.73

3.0

2.5

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.99

0.72

1.4

1.2

—

Vasomotor and allergic rhinitis

106

0.56

0.72

2.2

4.9

—

Other congenital malformations

1.61

0.72

4.7

6.8

—

Mood [affective] disorders

126

1.36

0.72

2.0

2.9

—

Sleep apnoea

0.62

0.71

2.6

2.1

—

Mood disorders

126

1.36

0.71

2.0

2.9

—

Dorsalgia

113

0.67

0.71

2.6

2.8

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1.95

0.71

4.0

2.0

—

Undescended testicle

1.93

0.70

8.2

7.0

—

Weight loss

1.92

0.70

8.0

5.0

—

5-aminosalicylic acid

1.92

0.70

5.0

2.9

—

Dental caries 2, only avohilmo

139

1.36

0.70

2.5

4.3

—

Transport accidents

1.51

0.69

3.2

3.7

—

Gonarthrosis,primary

0.52

0.69

1.0

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.88

0.69

1.0

1.5

—

Pre-eclampsia or poor fetal growth

1.85

0.68

1.0

1.4

—

Other arthrosis

1.66

0.68

1.6

1.5

—

Dorsopathies

135

0.72

0.67

2.9

3.4

—

Pain in throat and chest

1.39

0.67

3.1

3.0

—

Redundant prepuce, phimosis and paraphimosis

1.62

0.66

6.6

4.7

—

Myopia

1.79

0.66

6.0

4.7

—

Asthma, hospital admissions , main diagnosis only

168

1.33

0.66

3.8

4.0

—

Major coronary heart disease event excluding revascularizations

1.64

0.65

1.1

1.5

—

Injuries to the wrist and hand

161

1.31

0.65

1.7

4.0

—

Other disorders of veins

1.72

0.63

1.0

1.4

—

Open wound of wrist and hand

1.50

0.63

1.4

3.2

—

Sleep disorders (combined)

117

0.67

0.63

2.9

2.8

—

Fracture of lower leg, including ankle

1.49

0.62

3.3

3.5

—

Prolonged pregnancy

0.00

0.60

0.0

1.7

—

Benzodiazepine use

117

0.67

0.60

2.1

—

Autism spe

0.00

0.60

0.0

5.7

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.60

0.0

1.5

—

Malignant neoplasm of breast, HER-positive

0.00

0.60

0.0

1.3

—

Other/unspecified dorsalgia

1.56

0.60

3.5

2.6

—

Allergic contact dermatitis

0.00

0.60

0.0

3.6

—

Mental retardation

1.54

0.59

7.0

7.5

—

Mental retardation, wide definition

1.54

0.59

7.0

7.5

—

Eating disorder

0.00

0.59

0.0

4.0

—

Congenital malformations of genital organs

1.53

0.59

6.8

—

COPD, hospital admissions

1.75

0.58

1.0

2.1

—

COPD, early/later onset

1.75

0.58

1.0

2.1

—

Other disorders of patella

0.00

0.58

0.0

1.8

—

Other and unspecified urticaria

1.51

0.58

6.5

4.7

—

Congenital malformations of eye, ear, face and neck

1.72

0.57

4.5

7.0

—

COPD

1.71

0.57

1.0

2.2

—

Other diseases of anus and rectum

1.71

0.57

2.8

3.6

—

Dental caries 1, only avohilmo

113

0.72

0.56

2.9

4.7

—

Spondylopathies

0.63

0.56

1.5

1.7

—

Personality disorders

1.62

0.55

1.8

—

Disorders of the thyroid gland

103

1.33

0.55

1.9

2.8

—

Infections specific to the perinatal period

1.59

0.54

8.3

7.1

—

Type of accident

1.48

0.53

6.1

3.5

—

Disorders of breast

1.54

0.53

1.3

1.8

—

Allergic colitis

1.54

0.53

8.7

6.5

—

Leisure time condition

1.54

0.53

5.5

3.7

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.43

0.52

1.1

1.7

—

Mental and behavioural disorders due to psychoactive substance use

1.43

0.52

2.1

—

Use of hypnotics and sedatives

102

1.30

0.52

1.7

2.8

—

Cholelithiasis, broad definition with cholecystitis

1.44

0.51

2.5

1.7

—

Depression or dysthymia

1.42

0.51

2.6

1.9

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.60

0.51

3.0

3.7

—

Atopic dermatitis, strict definition with reimbursement

1.40

0.51

5.1

5.2

—

Type 1 diabetes, definitions combined

1.40

0.51

2.3

6.3

—

Non-rheumatic valve diseases

1.49

0.51

3.9

4.1

—

Type 1 diabetes, strict (exclude DM2)

1.38

0.50

2.3

6.2

—

Sensorineural hearing loss

1.38

0.49

5.4

2.9

—

Dental pulpitis 3

0.63

0.49

4.0

6.3

—

Angina pectoris

1.52

0.48

1.1

1.4

—

Valvular heart disease excluding rheumatic fever

1.44

0.48

5.7

4.5

—

Other joint disorders

120

0.75

0.48

2.9

3.8

—

Gonarthrosis [arthrosis of knee](FG)

0.58

0.47

1.0

1.3

—

Appendectomy

1.39

0.46

3.1

2.0

—

Dyspnoea

118

1.30

0.46

1.7

3.9

—

Cholelithiasis

1.43

0.46

2.4

1.7

—

Diseases of inner ear

1.43

0.46

1.3

1.8

—

Other functional intestinal disorders

106

1.35

0.45

4.5

5.3

—

Fall on same level involving ice and snow

0.60

0.45

3.0

3.1

—

Appendicitis, broad definition

102

1.34

0.45

2.3

1.9

—

Diseases of appendix

102

1.34

0.44

2.3

1.9

—

Postmenopausal atrophic vaginitis

0.00

0.43

0.0

1.3

—

Postpartum care and examination

0.00

0.42

0.0

1.5

—

Injuries to the knee and lower leg

146

1.22

0.42

2.7

3.6

—

Substance abuse

1.38

0.42

1.5

2.1

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.38

0.41

7.1

—

Liveborn infants according to place of birth

0.00

0.41

0.0

5.9

—

Impacted maxillary canine

0.00

0.41

0.0

5.3

—

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

7.0

—

Irritable bowel syndrome

1.52

0.41

1.0

3.0

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.2

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.41

0.0

3.7

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.35

0.41

7.1

7.0

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.40

0.0

6.8

—

Specific personality disorders

1.47

0.40

1.8

1.6

—

Effects of foreign body entering through natural orifice

1.33

0.40

3.4

4.7

—

Dislocation, sprain and strain of joints and ligaments of knee

0.67

0.39

2.6

2.5

—

Constipation

147

0.78

0.39

3.5

4.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.43

0.39

5.0

2.9

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.39

0.0

6.6

—

Combinations of oral blood glucose lowering drugs

0.00

0.39

0.0

1.5

—

Disorders of vestibular function (Vertigo)

1.38

0.38

1.2

1.9

—

Dental caries 3, only avohilmo

127

0.81

0.37

3.3

4.5

—

Gonarthrosis

0.62

0.37

1.0

1.3

—

Alcohol use disorder, Swedish definition

1.36

0.36

1.5

1.9

—

Intracranial injury

130

0.74

0.35

4.3

4.6

—

Abnormalities of heart beat

1.42

0.35

3.2

3.0

—

Obesity, other/unspecified

1.40

0.35

1.8

2.6

—

Other chronic obstructive pulmonary disease, including avohilmo

1.35

0.34

1.0

1.9

—

Cardiac arrhythmias

1.27

0.34

2.1

4.4

—

Disorders of adult personality and behaviour

1.33

0.33

3.0

1.9

—

Episodal and paroxysmal disorders

164

0.84

0.33

3.3

4.2

—

Other arthritis (FG)

1.30

0.33

3.3

3.5

—

Dental operations, only avohilmo

1.26

0.32

3.8

4.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.67

0.32

6.7

3.9

—

Type 2 diabetes, definitions combined

0.71

0.32

1.6

1.5

—

Type 2 diabetes, strict (exclude DM1)

0.70

0.31

1.6

1.5

—

Type 2 diabetes, definitions combined, including avohilmo

0.69

0.31

1.6

1.5

—

Congenital malformations of cardiac septa

1.34

0.31

4.4

7.2

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.33

0.31

1.7

1.5

—

Carpal tunnel syndrome

1.24

0.29

1.3

—

Deforming dorsopathies

1.23

0.29

2.3

3.8

—

Allergic conjunctivitis

117

0.76

0.27

5.7

3.6

—

Pain in joint

1.27

0.27

2.6

3.6

—

Focal epilepsy

1.23

0.27

4.4

5.2

—

Injuries to the hip and thigh

1.20

0.26

3.3

4.0

—

Acute appendicitis

1.25

0.26

1.8

2.0

—

Obesity due to excess calories

0.68

0.26

1.8

4.1

—

Meniscus derangement

1.21

0.25

1.9

1.2

—

Haemorrhagic and haematological disorders of fetus and newborn

1.20

0.25

5.7

6.8

—

Malignant neoplasm of skin

1.34

0.23

1.0

1.4

—

Shoulder lesions

1.27

0.23

1.1

1.3

—

Dental pulpitis 4

138

0.87

0.23

2.0

4.2

—

Diseases of pulp and periapical tissues, including avohilmo

138

0.87

0.23

2.0

4.2

—

Intracranial trauma

110

0.81

0.23

3.8

4.8

—

Dental pulpitis 1

138

0.87

0.23

2.0

4.2

—

Atrial septal defect

1.27

0.22

3.6

6.9

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.19

0.21

1.8

1.2

—

AV-block

0.00

0.21

0.0

4.6

—

Congenital malformations of larynx

0.00

0.21

0.0

4.9

—

Other congenital malformations of skull and face bones

0.00

0.21

0.0

5.5

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Complex cardiac defects

0.00

0.21

0.0

6.8

—

Other specified/unspecified arthritis

1.19

0.21

3.2

3.7

—

Diseases of liver

1.19

0.21

2.4

2.5

—

Disorder of the sleep-wake schedule

0.00

0.21

0.0

5.9

—

Autism spe, excluding more controls

0.00

0.21

0.0

6.0

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

5.5

—

Burn and corrosion of wrist and hand

0.00

0.21

0.0

4.8

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.5

—

Recurrent dislocation and subluxation of joint

0.00

0.21

0.0

1.9

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

2.7

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

5.0

—

Psoriatic arthropathies

0.00

0.21

0.0

1.7

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

2.2

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.7

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.8

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Lichen planus, including avohilmo

0.00

0.21

0.0

1.9

—

Malignant neoplasm of breast, HER-negative

0.00

0.21

0.0

1.2

—

Polyarthrosis

0.00

0.21

0.0

1.7

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.21

0.0

5.8

—

Major anomalies of jaw size

0.00

0.21

0.0

5.3

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.21

0.0

6.3

—

Foreign body in alimentary tract

0.00

0.21

0.0

5.9

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

4.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

2.5

—

Injury of unspecified body region

0.00

0.21

0.0

4.5

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.2

—

Acute and transient psychotic disorders

0.00

0.21

0.0

1.7

—

Radiculopathy

0.00

0.21

0.0

1.8

—

Other abnormal uterine and vaginal bleeding

0.00

0.21

0.0

1.6

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

3.8

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

3.8

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

3.8

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.21

0.0

1.9

—

Other disorders of amniotic fluid and membranes

0.00

0.20

0.0

1.3

—

Unspecific neurodegenerative disorder

0.00

0.20

0.0

1.1

—

Childhood allergy (age < 16)

1.20

0.20

4.6

5.9

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.20

0.0

6.6

—

Other eating disorders

0.00

0.20

0.0

4.9

—

Assault by bodily force

0.00

0.20

0.0

2.5

—

FESS (DNB20)

0.00

0.20

0.0

2.8

—

Ethmoidectomy

0.00

0.20

0.0

2.8

—

Primary coxarthrosis, bilateral

0.00

0.20

0.0

1.6

—

Exposure to other specified factors

163

1.15

0.19

2.3

3.8

—

Congenital malformations of great arteries

1.16

0.19

4.3

7.3

—

Glucagon-like peptide-1 (GLP-1) analogues

1.15

0.19

1.3

—

Internal derangement of knee

1.13

0.18

2.0

2.1

—

Alcohol use disorder, ICD-based

1.17

0.17

1.1

1.8

—

Dermatitis due to ingested food

0.76

0.17

5.8

6.9

—

Rotator cuff syndrome

1.19

0.17

1.1

1.3

—

Cholecystectomy

1.18

0.16

2.3

1.5

—

Septal defects

1.14

0.15

4.8

7.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.80

0.14

3.7

2.9

—

Dizziness and giddiness

0.80

0.13

1.5

2.5

—

Asthma (diagnoses ohter than nonallergic)

170

1.11

0.13

4.4

4.1

—

Atopic dermatitis, strict definition

120

1.14

0.13

5.1

—

Selective serotonin reuptake inhibitors

117

0.90

0.13

2.0

2.9

—

Acute appendicitis, no complications

1.17

0.12

2.0

—

Atopic dermatitis

122

1.12

0.11

4.8

4.4

—

Concussion

109

0.87

0.11

3.9

4.7

—

Obesity related asthma

1.14

0.10

2.6

3.0

—

Other symptoms and signs involving cognitive functions and awareness

1.07

0.09

1.2

2.3

—

Injuries to the shoulder and upper arm

139

0.90

0.09

2.5

3.3

—

Recurrent or chronic depression

1.06

0.08

1.3

1.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.05

0.08

1.3

3.9

—

Other arrhythmias

1.14

0.08

1.6

3.1

—

Superficial injury of lower leg

0.82

0.08

2.0

3.8

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.03

0.08

8.9

6.8

—

Other fall from one level to another

1.04

0.07

3.8

5.8

—

Falls/tendency to fall

159

0.94

0.07

4.6

3.9

—

Other external causes of accidental injury

113

0.93

0.07

4.0

4.1

—

Other antidepressants

1.08

0.06

1.8

2.0

—

Obesity

100

0.89

0.06

1.9

3.3

—

Obesity and other hyperalimentation

101

0.88

0.06

1.9

3.3

—

Asthma/COPD (KELA code 203)

165

0.94

0.06

4.0

3.8

—

Other diseases of upper respiratory tract

149

1.05

0.05

4.1

4.0

—

Other specific joint derangements/joint disorders

108

0.93

0.05

2.4

3.6

—

Other (not insulin) diabetes medications

0.91

0.04

1.6

1.5

—

Other nutritional deficiencies

106

0.92

0.03

1.8

3.5

—

Arthropathies

132

1.04

0.03

3.0

4.1

—

Epilepsy

1.07

0.01

4.2

5.2

—

Dental caries 2 and operation codes, only avohilmo

147

0.97

0.01

2.6

4.3

—

Exclusions for E4_PCOS_CONSORTIUM

110

1.03

0.00

5.1

4.2

—

Asthma, including avohilmo

174

1.00

0.00

3.6

3.8

—

Migraine

1.00

0.00

3.0

4.1

—

Injuries to the head

179

1.02

0.00

4.0

3.8

—

Unspecified fall

120

0.99

0.00

4.8

5.1

—

Fall on same level

172

1.01

0.00

4.1

3.9

—

Open wound of head

128

1.00

0.00

5.0

4.4

—

Chronic lower respiratory diseases

170

1.02

0.00

3.6

3.9

—

Accidents

113

1.02

0.00

3.8

4.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

121

0.98

0.00

1.9

2.8

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.8

—

Inflammatory bowel disease, strict (require KELA)

0.93

0.00

5.0

3.4

—

Nummular dermatitis

0.00

0.0

1.7

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

Disorder of visual pathways, unspecified

0.00

0.0

5.8

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Unspecified jaundice

0.00

0.0

5.0

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.0

3.5

—

Lichen planus

0.00

0.0

1.0

—

Struck by thrown, projected or falling objec

0.00

0.0

5.5

—

Operations 1 for CAVS

0.00

0.0

8.0

—

Failed induction of labour

0.00

0.0

1.2

—

Psoriatic arthropathies, ICD10

0.00

0.0

2.1

—

Lactose intolerance

0.00

0.0

4.8

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.2

—

Open wound of hip and thigh

0.00

0.0

4.4

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.6

—

Injury of intra-abdominal organs

0.00

0.0

4.7

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

0.0

2.0

—

Focal epilepsy, strict definition

1.00

0.00

4.3

5.1

—

Digestive system disorders of fetus and newborn

0.00

0.0

6.3

—

Other congenital malformations of peripheral vascular system

0.00

0.0

4.3

—

Metatarsalgia

0.00

0.0

2.9

—

Other headache syndromes

1.02

0.00

1.0

2.5

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.0

1.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

0.0

6.2

—

Ulcerative proctitis

0.00

0.0

3.4

—

malignant neoplasm of female genital organs

0.00

0.0

2.4

—

Alzheimer disease, including avohilmo

0.00

0.0

1.1

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

6.2

—

Malignant neoplasm of bronchus and lung

0.00

0.0

1.0

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.0

4.5

—

D07AA Corticosteroids, weak (group I)

1.00

0.00

3.3

6.1

—

Other and unspecified visual disturbances

0.00

0.0

3.6

—

Multiple delivery

0.00

0.0

1.3

—

Maxillary prognathism

0.00

0.0

4.9

—

Twin gestation

0.00

0.0

1.3

—

Abnormal spermatozoa

0.00

0.0

1.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

4.8

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

3.4

—

Other osteochondrodysplasias

0.00

0.0

5.6

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.0

3.6

—

Congenital malformations of lung

0.00

0.0

4.8

—

Microcephaly

0.00

0.0

4.6

—

Other perinatal haematological disorders

0.00

0.0

5.5

—

Other psoriatic arthropathies

0.00

0.0

2.3

—

Benign leiomyoma with endometriosis

0.00

0.0

1.2

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

5.1

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

N06DA Anticholinesterases

0.00

0.0

1.1

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

6.8

—

L02BA Anti-estrogens

0.00

0.0

1.2

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.0

5.8

—

Malignant neoplasm of endocrine gland

0.00

0.0

4.4

—

Spermatocele

0.00

0.0

2.3

—

Colon adenocarcinoma

0.00

0.0

1.0

—

Parkinson's disease

0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

0.0

2.6

—

Uterine polyps

0.00

0.0

1.2

—

Neonatal jaundice from other and unspecified causes

0.95

0.00

4.7

7.0

—

Sudden idiopathic hearing loss

0.00

0.0

2.3

—

Lactose intolerance, other/unspecified

0.00

0.0

4.8

—

Reimbursement for rheumatic diseases

0.91

0.00

4.4

3.8

—

Transient global amnesia

0.00

0.0

1.0

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

3.1

—

Temporomandibular joint disorders, including avohilmo

0.88

0.00

1.3

2.4

—

Other bursopathies

0.00

0.0

3.0

—

Polycystic ovarian syndrome, broad definition

0.00

0.0

1.2

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

2.4

—

IBD patients in KELA-register

1.02

0.00

5.0

3.4

—

Other disorders of pigmentation

0.00

0.0

4.6

—

Benign mammary dysplasia

0.00

0.0

1.1

—

Toxic effect of contact with venomous animals

0.00

0.0

5.4

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

Burns classified according to extent of body surface involved

0.00

0.0

3.7

—

Inflammatory bowel disease

0.95

0.00

4.5

3.5

—

Congenital malformations of great veins

0.00

0.0

6.3

—

Other and unspecified injuries of head

0.00

0.0

5.1

—

Open wound of abdomen, lower back and pelvis

0.00

0.0

4.8

—

Other pulmonary heart/vessel disease

0.00

0.0

3.9

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

3.8

—

Alzheimer’s disease, wide definition

0.00

0.0

1.0

—

Varicose veins of other sites

0.00

0.0

3.6

—

Adenomyosis (Endometriosis of uterus)

0.00

0.0

1.1

—

Benign leiomyoma with endometriosis

0.00

0.0

1.3

—

Cervicocranial syndrome

0.00

0.0

1.9

—

Pregnancy with abortive outcome

0.90

0.00

1.0

1.7

—

Foreign body or object entering through skin

0.00

0.0

4.0

—

Leiomyoma of uterus

0.89

0.00

1.0

1.3

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

Unspecified event, undetermined intent

0.00

0.0

5.2

—

Wet age-related macular degeneration

0.00

0.0

1.0

—

Striking against or struck by other objects

0.94

0.00

1.9

4.6

—

Type1 diabetes, definitions combined, early onset

0.98

0.00

3.0

6.3

—

Other perinatal digestive system disorders

0.00

0.0

6.0

—

Sleep disorders, other/unspecified

0.00

0.0

3.7

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

5.4

—

Constitutional tall stature

0.00

0.0

4.6

—

Rheumatism, unspecified

0.00

0.0

1.0

—

Psychotic depression

0.00

0.0

1.9

—

Poor fetal growth

0.00

0.0

1.7

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

2.2

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.92

0.00

1.0

3.7

—

Benign neoplasm of eye and adnexa

0.00

0.0

2.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

2.3

—

Pedal cyclist injured in transport accident

0.88

0.00

5.4

4.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.0

1.1

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.8

—

Memory loss

0.00

0.0

1.0

—

Ovarian dysfunction

0.00

0.0

2.3

—

Chronic sinusitis

0.93

0.00

3.0

2.1

—

Other obstructed labour

0.00

0.0

1.3

—

Nonalcoholic fatty liver disease

0.00

0.0

3.3

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

0.0

1.0

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.0

—

Malignant neoplasm of head and neck

0.00

0.0

2.6

—

Colorectal adenocarcinoma

0.00

0.0

2.1

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.0

4.6

—

Arthrosis

0.93

0.00

1.6

1.4

—

Medical abortion

0.99

0.00

1.3

1.7

—

Down's syndrome

0.00

0.0

4.9

—

Chronic laryngitis and laryngotracheitis

0.00

0.0

2.0

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

3.3

—

Multiple gestation

0.00

0.0

1.3

—

Other puerperal infections

0.00

0.0

1.1

—

Other obstetric trauma

0.00

0.0

1.1

—

Lichen simplex chronicus and prurigo

0.00

0.0

3.0

—

Alcoholic liver disease

0.00

0.0

2.3

—

Amiodarone users

0.00

0.0

2.3

—

Use of anticholinesterases

0.00

0.0

1.1

—

Use of memantine

0.00

0.0

1.0

—

Use of donepezil

0.00

0.0

1.0

—

Ulcerative colitis

1.02

0.00

5.2

3.4

—

Use of other anti-dementia drugs

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

2.6

—

Alzheimer disease

0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

6.2

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

6.0

—

Use of rivastigmine

0.00

0.0

1.0

—

Benign neoplasm of eye and adnexa

0.00

0.0

2.8

—

Parkinson's disease, excluding more controls

0.00

0.0

1.0

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.0

1.0

—

Phakomatoses, not elsewhere classified

0.00

0.0

6.3

—

Muscular dystrophy

0.00

0.0

7.0

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

4.3

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

2.0

—

0.00

-0.00

0.0

6.1

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS